Pharmaceutical group Adcock Ingram has managed to turn its rest of Africa operations profitable, contributing to a tripling of after-tax profit in the year to end-June. The group grew overall revenue by 7% to R5.96 billion and after-tax profit was up 213% to R561 million in the year to end-June. Aslam Dalvi comments.
view article